155 related articles for article (PubMed ID: 21205130)
1. Viral hepatitis in 2011: a major step forward.
Marcellin P
Liver Int; 2011 Jan; 31 Suppl 1():1-2. PubMed ID: 21205130
[No Abstract] [Full Text] [Related]
2. Editorial comment: triple infection with HIV and hepatitis B and C viruses--lesson in combination therapy.
Dore GJ
AIDS Read; 2004 Jul; 14(7):392. PubMed ID: 15282869
[No Abstract] [Full Text] [Related]
3. [Antiviral treatment of chronic hepatitis].
Müller R
Internist (Berl); 1984 Dec; 25(12):728-34. PubMed ID: 6083989
[No Abstract] [Full Text] [Related]
4. [The combination administration of interferon in viral hepatitis].
Zhao GD; Xie Q
Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):5-7. PubMed ID: 21272449
[No Abstract] [Full Text] [Related]
5. [Antiviral preparations in the therapy of chronic viral hepatitis].
Geller LI
Ter Arkh; 1990; 62(11):15-9. PubMed ID: 1710074
[TBL] [Abstract][Full Text] [Related]
6. Tri-infection: successful treatment of a patient infected with HIV and hepatitis B and C viruses--a case report.
Johanson F
AIDS Read; 2004 Jul; 14(7):389-94. PubMed ID: 15282868
[TBL] [Abstract][Full Text] [Related]
7. Antiviral agents in the treatment of chronic viral hepatitis.
Perrillo RP
Prog Liver Dis; 1992; 10():283-309. PubMed ID: 1284255
[No Abstract] [Full Text] [Related]
8. [Drugs active against hepatitis viruses].
Goudeau A
Rev Prat; 1997 Mar; 47(6):640-5. PubMed ID: 9183938
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B and C.
Karnsakul W; Schwarz KB
Pediatr Clin North Am; 2017 Jun; 64(3):641-658. PubMed ID: 28502443
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C and B viruses: the new opportunists in HIV infection.
Chung RT
Top HIV Med; 2006; 14(2):78-83. PubMed ID: 16835462
[TBL] [Abstract][Full Text] [Related]
11. [Therapy noncompliance in chronic viral hepatitis--standard therapy, prognostic parameters, treatment strategy].
Hopf U
Praxis (Bern 1994); 1997 Jan; 86(4):83-5. PubMed ID: 9064723
[No Abstract] [Full Text] [Related]
12. [When and how to treat hepatitis B and C?].
Pache I; Hess J; Gonvers JJ; Moradpour D
Rev Med Suisse; 2005 Jan; 1(3):237-41. PubMed ID: 15770818
[TBL] [Abstract][Full Text] [Related]
13. Antiviral therapy: quo vadis?
De Clercq E
Future Med Chem; 2010 Jul; 2(7):1049-53. PubMed ID: 21426154
[No Abstract] [Full Text] [Related]
14. [Prophylaxis, Diagnosis and Therapy of Hepatitis-B-Virus-(HBV-)Infection: upgrade of the guideline, AWMF-Register 021/011].
Cornberg M; Protzer U; Dollinger MM; Petersen J; Wedemeyer H; Berg T; Jilg W; Erhardt A; Wirth S; Schirmacher P; Fleig WE; Manns MP
Z Gastroenterol; 2007 Jun; 45(6):525-74. PubMed ID: 17554641
[No Abstract] [Full Text] [Related]
15. [Treatment of hepatitis B and C -- current standards].
Zeuzem S
Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S57-9. PubMed ID: 15368169
[No Abstract] [Full Text] [Related]
16. [Liver, biliary tracts and human immunodeficiency virus infection. 1:q liver, HIV and hepatitis B, C and D viruses].
Vuitton DA; Chossegros P; Bresson-Hadni S; Delfraissy JF; Kirn A; Marcellin P; Pol S; Saint-Paul MC
Gastroenterol Clin Biol; 1996; 20(3):269-80. PubMed ID: 8763066
[No Abstract] [Full Text] [Related]
17. [Characteristics of hepatitis and influenza antivirals: update 2009].
Lopez-Suñé E; Tuset M; Laguno M; Moreno A; Miró JM
Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):253.e1-17. PubMed ID: 20395018
[TBL] [Abstract][Full Text] [Related]
18. [The role of interferon in the treatment of viral hepatitis and its perspective].
Zhang DF
Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):2-4. PubMed ID: 21272448
[No Abstract] [Full Text] [Related]
19. [Effect of catergen on the course of acute viral hepatitis].
Babiuch L; Poznańska H; Rychalska B
Przegl Epidemiol; 1981; 35(4):471-7. PubMed ID: 6803308
[No Abstract] [Full Text] [Related]
20. Drug-resistant viral hepatitis.
Wright M; Main J; Thomas HC
J Infect; 2000 Jul; 41(1):1-4. PubMed ID: 10942634
[No Abstract] [Full Text] [Related]
[Next] [New Search]
